← Back to Search

Other

ICL for Myopia

Phase 4

Waitlist Available

Research Sponsored by Carolina Eyecare Physicians, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age: 21 to 45 years of age

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1-month

Awards & highlights

Study Summary

This trial is studying how the lens in your eye is affected after an implantable collamer lens (ICL) is placed in front of it. The ICL is a type of lens that can

Who is the study for?

This clinical trial is for individuals with moderate to severe near-sightedness (myopia), who are interested in an alternative to glasses or contact lenses. To participate, they must be eligible for the implantation of a lens inside their eye.Check my eligibility

What is being tested?

The study is testing the space ('vault') created between an implanted artificial lens (ICL) and the natural crystalline lens in patients' eyes. The ICL has been approved by the FDA for correcting vision in people with myopia.See study design

What are the potential side effects?

Potential side effects may include discomfort, redness, inflammation, increased eye pressure, or blurry vision after implantation. Long-term risks could involve cataract formation or damage to the cornea if vaulting is incorrect.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 21 and 45 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1-month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1-month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

• Mean difference between predicted and actual central vault at 1-month after ICL implantation

Trial Design

1Treatment groups

Experimental Treatment

Group I: ICLExperimental Treatment1 Intervention

ICL implantation

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Science in VisionOTHER

16 Previous Clinical Trials

783 Total Patients Enrolled

Carolina Eyecare Physicians, LLCLead Sponsor

10 Previous Clinical Trials

579 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the eligibility criteria to participate in this clinical study?

"To meet the criteria for participation, individuals must have myopia and fall within the age range of 21 to 45. The study aims to recruit approximately 33 eligible candidates."

Answered by AI

Is the age requirement for participation in this study limited to individuals below 80 years old?

"Individuals between the ages of 21 and 45 are eligible for recruitment into this clinical trial."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"According to the information available on clinicaltrials.gov, this particular study is currently not seeking participants. The trial was initially posted on January 29th, 2024 and last updated on January 19th, 2024. However, it's worth noting that there are presently 125 other studies actively enrolling patients at this time."

Answered by AI

What are the potential risks and safety concerns associated with implantable collamer lenses (ICL) for individuals?

"Based on the fact that this trial is classified as Phase 4, indicating approval of the treatment, our team at Power rates the safety of ICL with a score of 3."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Vault Evaluation After ICL Implantation

2024. "Vault Evaluation After ICL Implantation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06229119.

All > Myopia